[
    [
        {
            "time": "2018-06-14",
            "original_text": "[领先大市-B评级]医药行业动态分析：四价流感病毒裂解疫苗获批上市 国内流感疫苗布局进一步完善",
            "features": {
                "keywords": [
                    "四价流感病毒裂解疫苗",
                    "获批上市",
                    "流感疫苗",
                    "布局完善"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[领先大市-B评级]医药行业动态分析：四价流感病毒裂解疫苗获批上市 国内流感疫苗布局进一步完善",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-06-14",
            "original_text": "医药行业中期策略：聚焦服务、优质医药、商业三条主线(附股)",
            "features": {
                "keywords": [
                    "医药行业",
                    "中期策略",
                    "服务",
                    "优质医药",
                    "商业主线"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业中期策略：聚焦服务、优质医药、商业三条主线(附股)",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-06-14",
            "original_text": "6月14日券商晨会研报汇编",
            "features": {
                "keywords": [
                    "券商晨会",
                    "研报汇编"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "6月14日券商晨会研报汇编",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-06-14",
            "original_text": "[增持评级]医药生物行业事件点评：四价流感疫苗获批生产 预防流感疫情并拉动相关公司业绩增长",
            "features": {
                "keywords": [
                    "四价流感疫苗",
                    "获批生产",
                    "预防流感",
                    "业绩增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业事件点评：四价流感疫苗获批生产 预防流感疫情并拉动相关公司业绩增长",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-06-14",
            "original_text": "【东吴晨报0614】【固收】社融回落点评【行业】医药【个股】利安隆、成实外教育、康尼机电",
            "features": {
                "keywords": [
                    "东吴晨报",
                    "固收",
                    "社融回落",
                    "医药",
                    "利安隆",
                    "成实外教育",
                    "康尼机电"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【东吴晨报0614】【固收】社融回落点评【行业】医药【个股】利安隆、成实外教育、康尼机电",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-06-14",
            "original_text": "四价流感疫苗获批准入市场：流感疫苗市场格局生变",
            "features": {
                "keywords": [
                    "四价流感疫苗",
                    "获批准入",
                    "市场格局",
                    "变化"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "四价流感疫苗获批准入市场：流感疫苗市场格局生变",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]